Could these be symptoms of Polycystic Ovarian Syndrome or a hormone disparity?
o Dark hair appearing on breasts, big toes, above eyebrow line, below belly button and above top lip where on earth they weren't before.
o Body fleece growing thicker and faster
o Body hair growing spinal column over a wider range than it be previously if it is shaved or plucked
o Acne (face, back and shoulders)
I'm not sure if my period are irregular or not, though I don't believe they are. The flow is usually heavy and my cycle seem to be fairly long. I am slim and own a healthy BMI.
Thanks.
Answers: it sounds close to it but a simple blood test at the doctors will rule this out. But some times hormone change can give you these symtoms. if you enjoy had closely of stress over a period of time this can also affect your body, giving you some of these symtoms. to be on the out of danger side i would go to the doctors.
thats what it kinda sounds close to to me. but its nothing that can't be taken perfectionism of! just run to the gyn. in polycystic ovary disease, enlarged ovaries next to thickened sclerotic capsule and an abnormally giant number of follicles are present. The follicles may concurrently exist in varying states of growth, maturation, or atresia.
The prevalence of polycystic ovaries is difficult to accurately quantify. The inclusion criteria of most studies limitation participants to those near specific clinical symptoms or syndromes and thus preclude a full accounting. In other studies, control subjects without polycystic ovaries commonly have symptoms that are associated beside polycystic ovarian syndrome. Thus, a dilemma of nomenclature surrounds this clinical entity.
Most authors agree that polycystic ovaries are present in 3-7% of women worldwide. Almost 75% of women beside irregular menses and/or infertility may have polycystic ovaries, as determined near both radiologic and biochemical criteria. Polycystic ovaries have be found with ultrasonography surrounded by more than 50% of women with regular menstrual cycles as economically; however, most of these women had some level of hirsutism, acne, or male-pattern baldness
Mortality/Morbidity
* Infertility is the most common clinical finding within patients with polycystic ovarian syndrome. Low level of circulating FSH and increased androgen production in the ovary prevent follicular maturation and ovulation.
* Endometrial adenocarcinoma have been associated next to polycystic ovarian syndrome. Unopposed estrogenic stimulation of the endometrium is known to increase the risk of endometrial hyperplasia and its subsequent transformation into endometrial carcinoma. In totting up, the risk of breast cancer may be increased.
* Secondary effects of the elevated levels of circulating androgens include, but are not set to, hirsutism, abnormal or not at home menstrual cycles, virilization, and dysmenorrhea.
Sex
Polycystic ovarian disease occurs simply in females.
Age
* Polycystic ovaries can be diagnosed within patients of any age, from menarche through menopause.
* Typically, women in their 20s present beside difficulty conceiving.
* Although uncommon, some patients between ages 10 and 20 years present near primary amenorrhea.
Clinical Details
Most patients in whom polycystic ovarian syndrome is ultimately diagnosed initially present next to infertility, amenorrhea, or irregular menses. Although most woman present in their 20s or 30s, polycystic ovarian disease can affect females of any age, from menarche to menopause. Findings surrounded by almost 75% of patients meet the radiologic criteria for polycystic ovarian syndrome. Primary amenorrhea is a reputed but uncommon presentation.
Although infertility is the most adjectives presentation in artificial patients, polycystic ovarian syndrome may be associated with podginess and insulin resistance, among other symptoms. A number of patients are identified only when they present beside unrelated complaints; these patients may believe the symptoms that are associated with the syndrome are not of sufficient clinical significance to warrant medical attention.
A second population of patients presents near systemic signs of androgen excess—namely, hirsutism, acne, or male-pattern baldness. In approximately one half of the patients, sonograms show polycystic ovaries.
Additionally, a significant number of patients beside unrelated complaints are incidentally found to have polycystic ovaries. Further detailed clinical evaluation reveals that approximately one partially of the patients in this group enjoy typical signs and symptoms of the syndrome (ie, hirsutism, acne, infertility) and that one quarter have related symptoms such as flabbiness, irregular menses, or insulin resistance. The remaining one quarter of the patients may not have any clinically adjectives abnormality.
Preferred Examination
Polycystic ovaries are most often diagnosed by funds of laboratory studies. The initial screening tests may include determinations of the blood serum level of thyroid-stimulating hormone (TSH), FSH, LH, and prolactin (PL). The ratio of the FSH level to the LH horizontal is useful contained by the diagnosis. TSH or PL levels may be adjectives in identify an etiology, such as hyperthyroidism or a prolactinoma. In some patients, testosterone and dihydroepiandrosterone sulfate (DHEAS) levels or a progesterone brave are useful.
Typically, a radiologic evaluation for polycystic ovaries is reserved for patients who hold equivocal laboratory findings. However, radiologists make a significant number of incidental diagnoses. Should the radiologist's assistance be requested surrounded by the diagnosis of polycystic ovarian syndrome, the imaging method of choice is transabdominal and/or transvaginal ultrasonography. Magnetic resonance imaging (MRI) is useful as an nouns; however, although MRI is more sensitive than ultrasonography, its findings are less specific.
Polycystic ovarian syndrome is not a primary disease process. When polycystic ovaries are discovered at radiologic nouns, further diagnostic tests are needed to determine the etiology.
Polycystic ovaries typically exhibit 3 characteristics on ultrasonographic nouns: bilateral enlarged ovaries, multiple small follicles, and increased stromal echogenicity.
Usually, the ovaries are enlarged symmetrically, and the shapes change from ovoid to spherical. Ovarian volume can increase by as much as 6 mL; however, almost 30% of patients next to a biochemical and pathologic diagnosis of polycystic ovaries have no increase within ovarian volume.
The typical polycystic ovary contains numerous follicles at any given time. The follicles are small (0.5-0.8 cm), and no dominant follicle is present. Characteristically, the follicles are peripherally located in the cortex; however, they can turn out anywhere in the ovarian parenchyma. The diagnosis of polycystic ovaries should be reserved for patients near at least 5 of these follicles within each ovary.
Typically, the ovaries are hypoechoic contained by relation to the surrounding pelvic fat and myometrium. Polycystic ovaries repeatedly display increased echogenicity; however, as many as one third may remain isoechoic or hypoechoic relative to the myometrium.
Degree of Confidence
Ultrasonography have a largely corroborative role in the diagnosis of polycystic ovarian syndrome. In a long-suffering with a biochemical diagnosis of polycystic ovaries, ultrasonographic findings may confirm the clinical diagnosis, but they cannot exclude it. Alternatively, the incidental discovery of polycystic ovaries during ultrasonography is not a reliable indicator of polycystic ovarian syndrome.
What treatments are available for polycystic ovarian syndrome?
Treatment of PCOS depends in part on the woman's stage of life. For younger women who desire birth control, the birth control pill, especially those beside low "androgenic" (male hormone–like) side effects can cause regular period and prevent the risk of uterine cancer. For women who do not require birth control, treatments that cause a woman to hold a period four times a year is adjectives that is required.
For acne or excess mane growth, a water pill (diuretic) call spironolactone may be prescribed to help reverse these problems. The use of spironolactone requires occasional monitoring of blood test because of its potential effect on the blood potassium levels and kidney function. Propecia, a medication taken by men for hair loss, is another medication that blocks the effect of manly hormones on hair growth. Both of these medication can affect the development of a masculine fetus and should not be used if the woman desires to become pregnant.
For women who desire pregnancy, a medication called clomiphene (Clomid) can be used to induce ovulation (cause egg production). In mixing, weight loss can normalize menstrual cycles and normally increases the possibility of pregnancy in women next to PCOS. Other, more aggressive, treatments for infertility (including injection of gonadotropin hormones and assisted reproductive technologies) may also be required in women who desire pregnancy and do not become pregnant on Clomid psychoanalysis. Obesity that occurs beside PCOS needs to be treated because it can bring numerous additional medical problems. Consultation near a dietician on a frequent basis is considerate until just the right individualized program is established for respectively woman.
Metformin (Glucophage) is a medication used to treat type 2 diabetes. This drug affects the action of insulin and is adjectives in reducing the symptoms of PCOS.
Finally, a surgical procedure prearranged as ovarian drilling can help induce ovulation contained by some women who have not responded to other treatments for PCOS. In this procedure a small portion of ovarian tissue is destroyed by an electric current deliver through a needle inserted into the ovary.